| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/06/2002 | US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents |
| 06/06/2002 | US20020068345 98P7C3: homeodomain protein highly expressed in various cancers |
| 06/06/2002 | US20020068343 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 06/06/2002 | US20020068341 Human kallikrein |
| 06/06/2002 | US20020068329 Fusion proteins for prodrug activation |
| 06/06/2002 | US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/06/2002 | US20020068321 Splice choice antagonists as therapeutic agents |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068318 Production of human mutated proteins in human cells by means of homologous recombination |
| 06/06/2002 | US20020068313 Methods of diagnosing and treating crohn's disease using pseudomonas antigens |
| 06/06/2002 | US20020068306 Monitoring the activity of modulators on weight controlling membrane protein; obtain sample containing membrane protein, incubate with modulator, detect binding of modulator to membrane protein |
| 06/06/2002 | US20020068303 Protein for us ein the treatment of immunological defects |
| 06/06/2002 | US20020068302 Clasp-4 transmembrane protein |
| 06/06/2002 | US20020068291 Nucleotide sequences for use in treatment of cardiovascular, nervous system and cell proliferative disorders |
| 06/06/2002 | US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein |
| 06/06/2002 | US20020068288 Nucleotide sequences for use as anticarcinogenic agents in the treatment of tumors in lungs |
| 06/06/2002 | US20020068287 Methods of identifying integrin ligands using differential gene expression |
| 06/06/2002 | US20020068286 Detecting modulators of gene associated with weight control; obtain cells incubate with modulator, measure expression of preferential genes, compare to control |
| 06/06/2002 | US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/06/2002 | US20020068283 Suppressor mutations for common P53 cancer mutations |
| 06/06/2002 | US20020068279 Novel Proteins and nucleic acids encoding the same |
| 06/06/2002 | US20020068278 Protein for use as antitumor agent; for use as antimetastsis agent |
| 06/06/2002 | US20020068273 Mimetics and inhibitors of the interaction between Vpr (HIV vIral protein of regulation) and ANT (mitochondrial adenine nucleotide translocator) |
| 06/06/2002 | US20020068271 Methods for identifying agents capable of modulating protein kinase C theta (PKC0) activity |
| 06/06/2002 | US20020068103 A constitution improving agent for horses include collagen and proanthocyanidine |
| 06/06/2002 | US20020068092 Stabilizers prevent aggregation of nanoparticles and increase bioadhesion to substrates such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, and/or plant tissue |
| 06/06/2002 | US20020068083 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 06/06/2002 | US20020068072 Treating lichens, prurigo, pruriginous toxicoderma and severe pruritus of neurogenic origin |
| 06/06/2002 | US20020068071 Enhancement of the cellular immune response |
| 06/06/2002 | US20020068069 spsA polynucleotides and polypeptides |
| 06/06/2002 | US20020068066 Method for the treatment and prevention of dental caries |
| 06/06/2002 | US20020068062 Inhibitors of the formation of soluble human CD23 |
| 06/06/2002 | US20020068061 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions |
| 06/06/2002 | US20020068059 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection |
| 06/06/2002 | US20020068057 Administering a combination of a CD4+ T cell inhibiting agent, such as an antibody and a TNF antagonist; rheumatoid arthritis |
| 06/06/2002 | US20020068056 Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/06/2002 | US20020068055 Preventive and therapeutic antiviral drug for aids, hepatitis B, hepatitis C and influenza |
| 06/06/2002 | US20020068054 Therapeutic and cosmetic uses of heparanases |
| 06/06/2002 | US20020068053 Process for the production of anti-tumor Th1 cells |
| 06/06/2002 | US20020068050 Made by transfecting with an expression vector of a nucleotide sequence encoding an active agent such as cytokines or peptide hormones; use in transplantation to prevent tissue rejection, wound healing |
| 06/06/2002 | US20020068048 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 06/06/2002 | US20020068047 Treating a wound with an invasion inducing agent such as peptides containing PHSRN sequence |
| 06/06/2002 | US20020068043 Fusion protein, comprising a receptor-antagonizing domain (such as prolactin receptor antagonist) and a positive immunomodulator domain (such as an interleukin); combines apoptosis induction and immunotherapy |
| 06/06/2002 | US20020068013 Biomedical devices with antimicrobial coatings |
| 06/06/2002 | US20020067880 Optical switch |
| 06/06/2002 | EP1144454A3 Modified peptides as therapeutic agents |
| 06/06/2002 | DE10058596A1 Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung Method for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1-binding domain or a protein having an EVH1-binding domain and a method for the detection of said interaction |
| 06/06/2002 | DE10057290A1 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten To be administered enterally supplement for parenteral nutrition or partial enteral / oral nutrition in critically ill patients, chronically ill and malnourished |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | CA2436348A1 Preparation of large liposomes by infusion into peg |
| 06/06/2002 | CA2433665A1 Projection against mycobacterial infections |
| 06/06/2002 | CA2431839A1 Conjugates of glycosylated/galactosylated peptide |
| 06/06/2002 | CA2430924A1 Angiotensin receptor antagonist composition for the treatment of sexual dysfunction associated with hypertension and another condition |
| 06/06/2002 | CA2430745A1 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | CA2430584A1 Novel nucleic acids and polypeptides |
| 06/06/2002 | CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | CA2430495A1 Oncolytic virus |
| 06/06/2002 | CA2430473A1 Diagnosis and treatment of disease |
| 06/06/2002 | CA2430401A1 Uses of mammalian genes and related reagents |
| 06/06/2002 | CA2430365A1 Neurotoxins with enhanced target specificity |
| 06/06/2002 | CA2430341A1 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | CA2430334A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | CA2430298A1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | CA2430291A1 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma |
| 06/06/2002 | CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | CA2430239A1 A method of treating cancer |
| 06/06/2002 | CA2430199A1 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | CA2430139A1 Stable, aerosolizable suspensions of proteins in ethanol |
| 06/06/2002 | CA2430137A1 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations |
| 06/06/2002 | CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | CA2430077A1 Modified arginine deiminase |
| 06/06/2002 | CA2429987A1 Methods for the prevention and treatment of cancer using anti-c3b(i) antibodies |
| 06/06/2002 | CA2429819A1 Cytokine-like proteins |
| 06/06/2002 | CA2429814A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2429721A1 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429615A1 Determination of risk and treatment of complications of prematurity |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2429583A1 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 06/06/2002 | CA2429469A1 Human elongase genes and uses thereof |
| 06/06/2002 | CA2428595A1 Staphylococcus aureus protein staau_r2, gene encoding it and uses thereof |
| 06/06/2002 | CA2428552A1 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 06/06/2002 | CA2428026A1 Methods of treatment comprising administration of substance p |
| 06/06/2002 | CA2425872A1 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/05/2002 | EP1211319A2 Gene transfer into pancreatic and biliary epithelial cells |
| 06/05/2002 | EP1211315A1 Recombinant vectors for producing HCV envelope proteins |
| 06/05/2002 | EP1211313A2 Modulation of PDE11A activity |
| 06/05/2002 | EP1211311A2 Cord blood-derived activated lymphocytes and preparations containing said lymphocytes |
| 06/05/2002 | EP1211261A2 Stable polymerized hemoglobin blood-substitute |
| 06/05/2002 | EP1211249A1 Novel thiazine or pyrazine derivatives |
| 06/05/2002 | EP1210949A1 Antiulcer agents |
| 06/05/2002 | EP1210948A1 Remedies for nervous diseases |
| 06/05/2002 | EP1210947A1 Ophthalmic ointments for treating infective eye diseases |
| 06/05/2002 | EP1210941A2 Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS |
| 06/05/2002 | EP1210605A2 Analysis and treatment of body weight and eating disorders |
| 06/05/2002 | EP1210465A2 A method for producing quality assured biological sample and composition containing the same |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |